Expert Opinion on the Management of Growth Hormone Deficiency in Brain Tumor Survivors: Results From an Italian Survey

BACKGROUND: Growth hormone deficiency (GHD) is the first and most common endocrine complication in pediatric brain tumor survivors (BTS). GHD can occur due to the presence of the tumor itself, surgery, or cranial radiotherapy (CRT). AIMS: This study aimed to evaluate management and adherence to curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Iorgi, Natascia, Morana, Giovanni, Cappa, Marco, D’Incerti, Ludovico, Garrè, Maria Luisa, Grossi, Armando, Iughetti, Lorenzo, Matarazzo, Patrizia, Parpagnoli, Maria, Pozzobon, Gabriella, Salerno, Mariacarolina, Sardi, Iacopo, Wasniewska, Malgorzata Gabriela, Zucchini, Stefano, Rossi, Andrea, Maghnie, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331278/
https://www.ncbi.nlm.nih.gov/pubmed/35909559
http://dx.doi.org/10.3389/fendo.2022.920482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331278/
https://www.ncbi.nlm.nih.gov/pubmed/35909559
http://dx.doi.org/10.3389/fendo.2022.920482

Ejemplares similares